Examining the relationship between adherence and the number of cardiometabolic medications: Findings for patients with type 2 diabetes within a Tribal health care system
To our knowledge, this is the first study demonstrating the association between a higher number of cardiometabolic medications and better adherence in American Indian adults diagnosed with T2D whose medications were provided without cost to the patients. Medication cost is a well-known medication adherence barrier. Future studies should further examine factors associated with nonadherence in this population, such as younger age and fewer medications.
Authors
- Yingwei Yao (ORCID: https://orcid.org/0000-0001-5389-2717)
- Lisa Scarton (ORCID: https://orcid.org/0000-0003-1255-0811)
- Richard Segal
- Maria Eliza R. Aguila (ORCID: https://orcid.org/0000-0002-4034-4655)
- William T. Donahoo (ORCID: https://orcid.org/0000-0002-2126-860X)
- Anatolia B. Legaspi
- R. Turner Goins (ORCID: https://orcid.org/0000-0001-6875-1263)
- Diana J. Wilkie (ORCID: https://orcid.org/0000-0002-3954-8933)
- Tarah Nelson (ORCID: https://orcid.org/0000-0003-3080-8847)
- ASHLEY DEVAUGHAN CIRCLES
- Caterina Pierre
Institutions
- Western Carolina University (US)
- Oklahoma Health Care Authority (US)
- University of Florida (US)
- Florida College (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2025-05-30
- DOI
- https://doi.org/10.18553/jmcp.2025.31.6.590
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 0.00